Targeting a protein to help treat muscular dystrophy
PKR as a therapeutic target for muscular dystrophy
['FUNDING_R21'] · IOWA STATE UNIVERSITY · NIH-10673733
This study is looking at a protein called PKR to see how it affects inflammation and muscle problems in people with Duchenne muscular dystrophy (DMD), and by blocking PKR, the researchers hope to find a way to help keep muscles stronger and improve life for those with DMD.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | IOWA STATE UNIVERSITY (nih funded) |
| Locations | 1 site (AMES, UNITED STATES) |
| Trial ID | NIH-10673733 on ClinicalTrials.gov |
What this research studies
This research investigates the role of a protein called PKR in Duchenne muscular dystrophy (DMD), a severe genetic disorder that causes progressive muscle weakness. The study aims to understand how PKR contributes to inflammation and muscle dysfunction in patients with DMD. By inhibiting PKR, the researchers hope to reduce inflammation and stress in muscle cells, potentially leading to better preservation of muscle function. This approach could offer a new therapeutic strategy for managing DMD and improving patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Duchenne muscular dystrophy, particularly those experiencing early muscle weakness.
Not a fit: Patients with other forms of muscular dystrophy or unrelated muscle disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve muscle function and quality of life for patients with Duchenne muscular dystrophy.
How similar studies have performed: Previous research has shown promise in targeting similar pathways for muscle-related diseases, indicating potential for success in this novel approach.
Where this research is happening
AMES, UNITED STATES
- IOWA STATE UNIVERSITY — AMES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SELSBY, JOSHUA T — IOWA STATE UNIVERSITY
- Study coordinator: SELSBY, JOSHUA T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.